<SEC-DOCUMENT>0001209191-21-062724-index.html : 20211103
<SEC-HEADER>0001209191-21-062724.hdr.sgml : 20211103
<ACCEPTANCE-DATETIME>20211103164831
ACCESSION NUMBER:		0001209191-21-062724
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20211101
FILED AS OF DATE:		20211103
DATE AS OF CHANGE:		20211103

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Andersen Jill
		CENTRAL INDEX KEY:			0001891047

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40703
		FILM NUMBER:		211376216

	MAIL ADDRESS:	
		STREET 1:		303 WYMAN STREET
		STREET 2:		SUITE 300
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adagio Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001832038
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				851403134
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		303 WYMAN STREET
		STREET 2:		SUITE 300
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		(781) 530-3600

	MAIL ADDRESS:	
		STREET 1:		303 WYMAN STREET
		STREET 2:		SUITE 300
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>doc3a.xml
<DESCRIPTION>FORM 3/A SUBMISSION
<TEXT>
Document 1 - file: doc3a.html

Document 1 - RAW XML: doc3a.xml

</DOCUMENT>
</SEC-DOCUMENT>